Welcome to our dedicated page for Concord Medical SEC filings (Ticker: CCM), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Concord Medical Services Holdings Limited filings document the formal disclosures of a foreign private issuer operating oncology healthcare services in China. Annual reports and current reports cover audited financial statements, hospital and network business results, cancer-care operations, radiotherapy and diagnostic imaging services, proton therapy assets, and governance disclosures.
Form 6-K filings record shareholder meeting materials, proxy forms, director changes, interim and annual disclosures from Concord Healthcare Group, and capital actions at the Hong Kong-listed subsidiary. The filing record also documents public-company reporting around Form 20-F status, ordinary-share governance, subsidiary H-share activity, and material press releases furnished to the SEC.
Concord Medical Services Holdings Ltd director Zhang Liping filed an initial ownership report on Form 3. The filing shows direct ownership of 135,000 Class A ordinary shares, each with a par value of US$0.0001. This form records existing holdings rather than a new purchase or sale.
Concord Medical Services Holdings Limited reported that Mr. Yue Yu resigned from its board of directors, effective September 29, 2025. The company states that his resignation is due to personal reasons and that it is not related to any disagreement with the company regarding its operations, policies, or practices. This indicates a board change without an underlying disclosed dispute over how the business is run.
Concord Medical Services Holdings Limited filed a report noting that its subsidiary, Concord Healthcare Group Co., Ltd., announced interim results on the Main Board of The Stock Exchange of Hong Kong Limited for the six months ended June 30, 2025. Concord Healthcare’s H shares trade on the HKSE under stock code 2453.HK, while the parent company remains listed on the NYSE under the symbol CCM.
The filing directs investors to the Hong Kong exchange website for detailed information on Concord Healthcare’s transactions and interim financial results.
Concord Medical Services Holdings Ltd. (NYSE: CCM) has filed a Form 6-K to disclose that its Hong Kong–listed subsidiary, Concord Healthcare Group Co., Ltd. (HKSE: 2453.HK), signed a placing agreement on 22 July 2025 with Guotai Junan Securities (Hong Kong). Under the agreement the placing agent will, on a best-effort basis, place 48,723,600 new H-shares with at least six independent investors at HK$5.54 per share. The issuance will be made under Concord Healthcare’s existing general mandate. No financial statements, earnings figures or projected proceeds were provided in the filing.
The transaction increases Concord Healthcare’s share count and is intended to raise fresh capital for the subsidiary; however, the filing does not state the specific use of proceeds or anticipated dilution for Concord Medical’s shareholders. The parent reiterates that additional details on the subsidiary’s Hong Kong transactions can be found on the HKEX website.